Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Patheon
|
| gptkbp:acquired |
gptkb:Thermo_Fisher_Scientific
|
| gptkbp:acquisition |
gptkb:2017
|
| gptkbp:business_model |
contract manufacturing organization
|
| gptkbp:ceo |
gptkb:Marc_N._Casper
|
| gptkbp:employees |
over 10,000
|
| gptkbp:founded |
gptkb:1974
|
| gptkbp:founder |
gptkb:Dr._John_A._Mc_Gowan
|
| gptkbp:headquarters |
gptkb:Durham,_North_Carolina
|
| https://www.w3.org/2000/01/rdf-schema#label |
Patheon Pharmaceuticals
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:location |
gptkb:Europe
gptkb:Asia gptkb:United_States gptkb:Native_American_tribe |
| gptkbp:operates_in |
global market
|
| gptkbp:parent_company |
gptkb:Thermo_Fisher_Scientific
|
| gptkbp:revenue |
$1.5 billion (2016)
|
| gptkbp:services |
contract development and manufacturing
|
| gptkbp:specializes_in |
biologics
small molecules |
| gptkbp:website |
www.patheon.com
|